These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 22836615

  • 1. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
    Mroz RM, Minarowski L, Chyczewska E.
    Adv Exp Med Biol; 2013; 756():23-8. PubMed ID: 22836615
    [Abstract] [Full Text] [Related]

  • 2. Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.
    Singh MP.
    Int J Chron Obstruct Pulmon Dis; 2013; 8():613-9. PubMed ID: 24353411
    [Abstract] [Full Text] [Related]

  • 3. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
    Matsushima S, Inui N, Yasui H, Kono M, Nakamura Y, Toyoshima M, Shirai T, Suda T.
    Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial.
    Beaulieu J, Jensen D, O'Donnell DE, Brouillard C, Tracey L, Vincent S, Nadreau É, Bernard E, Bernard S, Maltais F.
    Ther Adv Respir Dis; 2020 Feb; 14():1753466620939507. PubMed ID: 32663102
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study.
    Fujimoto K, Yamazaki H, Ura M, Kitaguchi Y.
    Int J Chron Obstruct Pulmon Dis; 2017 Feb; 12():3195-3201. PubMed ID: 29138547
    [Abstract] [Full Text] [Related]

  • 7. FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.
    Mahler DA, Kerwin E, Ayers T, FowlerTaylor A, Maitra S, Thach C, Lloyd M, Patalano F, Banerji D.
    Am J Respir Crit Care Med; 2015 Nov 01; 192(9):1068-79. PubMed ID: 26177074
    [Abstract] [Full Text] [Related]

  • 8. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease.
    Nishijima Y, Minami S, Yamamoto S, Ogata Y, Koba T, Futami S, Komuta K.
    Int J Chron Obstruct Pulmon Dis; 2015 Nov 01; 10():439-44. PubMed ID: 25767381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
    Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D.
    Respir Med; 2013 Feb 01; 107(2):223-32. PubMed ID: 23219347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.
    Inui N, Matsushima S, Kato S, Yasui H, Kono M, Fujisawa T, Enomoto N, Nakamura Y, Toyoshima M, Suda T.
    Int J Chron Obstruct Pulmon Dis; 2015 Feb 01; 10():1139-46. PubMed ID: 26124653
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
    Kerstjens HA, Deslée G, Dahl R, Donohue JF, Young D, Lawrence D, Kornmann O.
    Pulm Pharmacol Ther; 2015 Jun 01; 32():101-8. PubMed ID: 25743376
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
    Manoharan A, Morrison AE, Lipworth BJ.
    Lung; 2016 Apr 01; 194(2):259-66. PubMed ID: 26758884
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.